相似文献
1
We need to determine who benefits most from flu treatments.
BMJ. 2003 Jun 7;326(7401):1239-40. doi: 10.1136/bmj.326.7401.1239.
2
Neuraminidase inhibitors for influenza.
N Engl J Med. 2005 Sep 29;353(13):1363-73. doi: 10.1056/NEJMra050740.
3
[New diagnostic possibilities and medications. Fit for influenza?].
MMW Fortschr Med. 2002 Nov 28;144(48):18.
4
Neuraminidase inhibitors and relief of influenza symptoms.
S D J Med. 2000 Mar;53(3):99-100.
5
[Neuraminidase inhibitor].
Nihon Rinsho. 2000 Nov;58(11):2293-8.
6
Review says oseltamivir and zanamivir should be kept for epidemics of flu.
BMJ. 2006 Jan 28;332(7535):196. doi: 10.1136/bmj.332.7535.196.
7
[Influenza].
Nihon Rinsho. 2003 Feb;61 Suppl 2:135-40.
8
[Neuraminidase inhibitors against influenza].
Med Monatsschr Pharm. 1999 Sep;22(9):262-4.
9
Neuraminidase inhibitors for treatment of influenza.
Am Fam Physician. 2004 Jun 15;69(12):2824.
10
Neuraminidase inhibitors slightly beneficial for shortening flu symptoms.
J Fam Pract. 2003 Oct;52(10):747-8.
本文引用的文献
1
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep. 2002 Apr 12;51(RR-3):1-31.
2
Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population.
J Am Geriatr Soc. 2001 Aug;49(8):1025-31. doi: 10.1046/j.1532-5415.2001.49204.x.
Zotero 插件